Echovirus IgA Control Serum BC135A

$94.00

Summary

Virion/Serion Diagnostic Kit Control for research use (RUO)
Echovirus IgA Control Serum
Applications: ELISA
IgA control serum
Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
3 mL

SKU: BC135A Categories: control serum, Virion/Serion kits Tags: Echovirus, ELISA control serum, IgA

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Echovirus reactive IgA
species reactivity	Echovirus
applications	ELISA
assay type	Indirect & quantitative
available size	3 mL

Echovirus IgA Control Serum BC135A

kit
Research area Infectious Disease
Storage Store at 2-8°C.
Associated products Echovirus Antigen (BA135VS01) Echovirus IgA Control Serum (BC135A) Echovirus IgG Control Serum (BC135G) Echovirus IgM Control Serum (BC135M) Echovirus IgG ELISA Kit (ESR135G) Echovirus IgA ELISA Kit (ESR135A) Echovirus IgM ELISA Kit (ESR135M)

target relevance

human antibody anti-Echovirus

Echovirus

Description
Group of enteroviruses that cause aseptic meningitis, febrile illness, and other systemic infections

Structure
Echoviruses (Enteric Cytopathic Human Orphan viruses) are non-enveloped, positive-sense, single-stranded RNA viruses belonging to the genus Enterovirus within the family Picornaviridae. The viruses possess an icosahedral capsid that protects the viral genome and contributes to their resistance to environmental conditions and many disinfectants. Echoviruses are transmitted primarily through the fecal-oral route, respiratory secretions, and direct contact with contaminated surfaces. Following infection, viral replication occurs in the gastrointestinal tract and upper respiratory tract before dissemination through the bloodstream to various tissues and organs. More than thirty echovirus serotypes have been identified, and they are distributed worldwide. Echoviruses are among the most common causes of enteroviral infections and are frequently associated with outbreaks in children, although infections occur in all age groups.

Diagnosis
The diagnosis of echovirus infection is performed through molecular, virological, and serological methods. Reverse transcription polymerase chain reaction (RT-PCR) is the preferred diagnostic method due to its high sensitivity and specificity and can detect viral RNA in cerebrospinal fluid, stool samples, throat swabs, blood, and other clinical specimens. Viral culture may be performed in specialized laboratories but has largely been supplanted by molecular testing. Serological assays can detect echovirus-specific antibodies and may be useful for epidemiological investigations or retrospective diagnosis. Laboratory confirmation is particularly important in patients presenting with meningitis, encephalitis, neonatal infections, myocarditis, or unexplained febrile illness.

Symptoms
Echovirus infections produce a broad spectrum of clinical manifestations ranging from asymptomatic infection to severe systemic disease. Common symptoms include fever, headache, sore throat, fatigue, muscle aches, nausea, vomiting, abdominal pain, and rash. Echoviruses are a major cause of aseptic meningitis, which typically presents with fever, severe headache, neck stiffness, photophobia, and cerebrospinal fluid pleocytosis. Less commonly, echoviruses may cause encephalitis, myocarditis, pericarditis, hepatitis, conjunctivitis, and neonatal sepsis-like illness. Newborns and immunocompromised individuals are at increased risk of severe disease, which may result in multi-organ involvement and significant morbidity. Most infections are self-limiting and resolve without long-term complications.

Data

FAQ & Publications

Frequently Asked Questions

What is the primary application of the Echovirus IgA Control Serum BC135A?

The Echovirus IgA Control Serum BC135A is primarily used as a control serum in ELISA assays to detect Echovirus reactive IgA antibodies.

Is the Echovirus IgA Control Serum BC135A ready to use or does it require dilution?

The Echovirus IgA Control Serum BC135A is provided ready-to-use and pre-diluted specifically for SERION ELISA classic and SERION ELISA antigen assays.

What are the storage conditions recommended for this control serum?

The Echovirus IgA Control Serum BC135A should be stored at 2-8°C to maintain its stability and performance.

Which species' antibodies does the Echovirus IgA Control Serum BC135A react with?

This control serum is reactive to Echovirus antibodies, which are relevant to human infectious disease research.

Can the Echovirus IgA Control Serum BC135A be used with indirect ELISA assay types?

Yes, the Echovirus IgA Control Serum BC135A is suitable for indirect and quantitative ELISA assays targeting Echovirus IgA.

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC135A protocol

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Echovirus IgA Control Serum BC135A

Data

FAQ & Publications

Protocols

Documents

Related Technical Resources & Posts

Reviews

Related Products

Candida albicans IgA Control Serum BC117A

Yersinia IgA Control Serum BC138A

Campylobacter jejuni IgA Control Serum BC139A

Respiratory Syncytial Virus IgA Control Serum BC113A

Brucella IgA Control Serum BC116A

Mycoplasma pneumoniae IgA Control Serum BC127A

Bordetella pertussis IgA Control Serum BC120A

Helicobacter pylori IgA Control Serum BC118A

Adenovirus IgA Control Serum BC128A

Enterovirus IgA Control Serum BC133A

Echovirus IgG Control Serum BC135G

Echovirus IgM Control Serum BC135M

Coxsackie IgA Virus Control Serum BC134A

Chlamydia trachomatis IgA Control Serum BC1372A

Chlamydia pneumoniae IgA Control Serum BC1371A